The HCV NS5B Nucleoside and Non-Nucleoside Inhibitors

被引：48
|
作者：
Membreno, Fernando E. [1 ]
Lawitz, Eric J. [1 ]
机构：
[1] Alamo Med Res, San Antonio, TX 78215 USA
来源：
CLINICS IN LIVER DISEASE | 2011年 / 15卷 / 03期
关键词：
Hepatitis C virus; NS5B nucleoside inhibitors; Non-nucleoside inhibitors; Polymerase inhibitors; HEPATITIS-C VIRUS; RNA-POLYMERASE INHIBITOR; ANTIVIRAL EFFICACY; HCVNS5B POLYMERASE; RESISTANCE; PROTEASE; INFECTION; PHARMACOKINETICS; PEGINTERFERON; TELAPREVIR;
D O I：
10.1016/j.cld.2011.05.003
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
This article introduces one of the most diverse classes of direct-acting antivirals for hepatitis C, the nucleoside and non-nucleoside NS5B polymerase inhibitors. Through a systematic review of the published literature, we describe their structure, mechanism of action, issues with resistance, and clinical effectiveness shown in the latest clinical trials. Direct-acting antiviral combination trials that have already shown some early promising results even in the setting of interferon-sparing antiviral regimens are discussed.
引用
收藏
页码：611 / +
页数：17
相关论文
共 50 条
  • [41] Structure-based optimization and derivatization of 2-substituted quinolone-based non-nucleoside HCV NS5B inhibitors with submicromolar cellular replicon potency
    Cheng, Yu
    Shen, Jian
    Peng, Run-Ze
    Wang, Gui-Feng
    Zuo, Jian-Ping
    Long, Ya-Qiu
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (12) : 2900 - 2906
  • [42] IDENTIFICATION AND CHARACTERIZATION OF PPI-383, A NEXT GENERATION HCV NS5B NON-NUCLEOSIDE INHIBITOR WITH POTENT ACTIVITY AGAINST ALL MAJOR HCV GENOTYPES
    Colonno, R.
    Huang, N.
    Lau, M.
    Huang, Q.
    Huq, A.
    Peng, E.
    Bencsik, M.
    Zhong, M.
    Li, L.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S464 - S464
  • [43] Novel 4-Thiazolidinones as Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B RNA-Dependent RNA Polymerase
    Cakir, Gizem
    Kucukguzel, Ilkay
    Guhamazumder, Rupa
    Tatar, Esra
    Manvar, Dinesh
    Basu, Amartya
    Patel, Bhargav A.
    Zia, Javairia
    Talele, Tanaji T.
    Kaushik-Basu, Neerja
    ARCHIV DER PHARMAZIE, 2015, 348 (01) : 10 - 22
  • [44] HCV NS5B Polymerase Inhibitors
    Burton, James R., Jr.
    Everson, Gregory T.
    CLINICS IN LIVER DISEASE, 2009, 13 (03) : 453 - +
  • [45] HCV NS5B polymerase inhibitors
    Watkins, William J.
    Ray, Adrian S.
    Chong, Lee S.
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2010, 13 (04) : 441 - 465
  • [46] NONCLINICAL AND CROSS-GENOTYPIC PROFILES OF GS-9669, A NOVEL HCV NS5B NON-NUCLEOSIDE THUMB SITE II INHIBITOR
    Fenaux, M.
    Tian, Y.
    Matles, M.
    Mabery, E.
    Zhang, Jingyu
    Eng, S.
    Murray, B.
    Mwangi, J.
    Lazerwith, S.
    Lew, W.
    Canales, E.
    Liu, Q.
    Byun, D.
    Doerffler, E.
    Ye, H.
    Clarke, M.
    Mertzman, M.
    Morganelli, P.
    Zhang, Jennifer
    Leavitt, S.
    Appleby, T.
    Hashash, A.
    Bidgood, A.
    Krawczyk, S.
    Watkins, W.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S476 - S476
  • [47] Nucleoside Inhibitors of Hepatitis C Virus NS5B Polymerase: A Systematic Review
    Xie, Yuanchao
    Ogah, Comfort Alicha
    Jiang, Xiangrui
    Li, Jianfeng
    Shen, Jingshan
    CURRENT DRUG TARGETS, 2016, 17 (13) : 1560 - 1576
  • [48] Non-nucleoside inhibitors of herpesviruses
    Wathen, MW
    REVIEWS IN MEDICAL VIROLOGY, 2002, 12 (03) : 167 - 178
  • [49] Non-nucleoside retrovirus inhibitors
    Sereni, D
    Lascoux, C
    Gomez, V
    PRESSE MEDICALE, 1996, 25 (08): : 361 - +
  • [50] Mechanism of Inhibition for BMS-791325, a Novel Non-nucleoside Inhibitor of Hepatitis C Virus NS5B Polymerase
    Rigat, Karen L.
    Lu, Hao
    Wang, Ying-Kai
    Argyrou, Argyrides
    Fanslau, Caroline
    Beno, Brett
    Wang, Yi
    Marcinkeviciene, Jovita
    Ding, Min
    Gentles, Robert G.
    Gao, Min
    Abell, Lynn M.
    Roberts, Susan B.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (48) : 33456 - 33468
12345